---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-25-000711"
form_type: "8-K"
ticker: "LEXX"
cik: "0001348362"
company_name: "Lexaria Bioscience Corp."
filed_at: "2025-04-28T23:59:59+00:00"
generated_at: "2026-05-23T04:48:54.147613+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Lexaria raises $2M via registered direct offering of common stock and pre-funded warrants

## Summary
- Gross proceeds $2M from sale of 2M shares/pre-funded warrants at $1.00 per share to one institutional investor.
- No new warrants issued to investor other than pre-funded warrants; placement agent gets 70,000 warrants at $1.25.
- Offering closed April 28, 2025; net proceeds for working capital and general corporate purposes.
- CEO states transaction minimized dilution during uncertain market; H.C. Wainwright acted as exclusive placement agent.

## SEC filing metadata
- accession: 0001640334-25-000711
- form_type: 8-K
- ticker: LEXX
- cik: 0001348362
- company_name: Lexaria Bioscience Corp.
- filed_at: 2025-04-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1348362/000164033425000711/0001640334-25-000711-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1348362/000164033425000711/lxrp_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-25-000711
- JSON: https://secwatch.observer/filing/0001640334-25-000711.json
- Plain text: https://secwatch.observer/filing/0001640334-25-000711.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.